Related Experiment Video
Updated: Jun 24, 2025

Reconstitution Of β-catenin Degradation In Xenopus Egg Extract
Published on: June 17, 2014
Covalent Degrader of the Oncogenic Transcription Factor β-Catenin
Flor A Gowans1,2, Nafsika Forte1,2, Justin Hatcher1,2
1Department of Chemistry, University of California, Berkeley, California 94720, United States.
Abstract:
β-catenin (CTNNB1) is an oncogenic transcription factor that is important in cell-cell adhesion and transcription of cell proliferation and survival genes that drive the pathogenesis of many different types of cancers. However, direct pharmacological targeting of CTNNB1 has remained challenging. Here, we have performed a screen with a library of cysteine-reactive covalent ligands to identify the monovalent degrader EN83 that depletes CTNNB1 in a ubiquitin-proteasome-dependent manner. We show that EN83 directly and covalently targets CTNNB1 three cysteines C466, C520, and C619, leading to destabilization and degradation of CTNNB1. Through structural optimization, we generate a highly potent and relatively selective destabilizing degrader that acts through the targeting of only C619 on CTNNB1. Our results show that chemoproteomic approaches can be used to covalently target and degrade challenging transcription factors like CTNNB1 through destabilization-mediated degradation.
Insights
Researchers developed EN83, a novel compound that degrades the oncogenic transcription factor beta-catenin (CTNNB1) via a proteasome-dependent pathway. This covalent targeting approach offers a new strategy for cancer therapy.
Area of Science:
- Oncology
- Molecular Biology
- Drug Discovery
Background:
- Beta-catenin (CTNNB1) is a key oncogenic transcription factor implicated in cancer pathogenesis.
- Targeting CTNNB1 pharmacologically has been a significant challenge in cancer research.
Purpose of the Study:
- To identify novel compounds capable of degrading CTNNB1.
- To explore covalent targeting strategies for challenging transcription factors.
Main Methods:
- Screening of cysteine-reactive covalent ligands.
- Identification and characterization of the monovalent degrader EN83.
- Structural optimization of the lead compound.
Main Results:
- EN83 was identified as a compound that depletes CTNNB1 through ubiquitin-proteasome degradation.
- EN83 covalently targets CTNNB1 at cysteines C466, C520, and C619, causing destabilization.
- An optimized degrader selectively targets C619, demonstrating high potency.
Conclusions:
- Chemoproteomic approaches can successfully target and degrade challenging transcription factors like CTNNB1.
- Destabilization-mediated degradation is a viable strategy for developing new cancer therapeutics.
Related Concept Videos
Catenins
Catenins in Cell Junctions
Catenins bind to cell adhesion molecules such as cadherins and link them to different cytoskeletal proteins depending on the type of cell junction. At the...
TGF - β Signaling Pathway
Canonical Wnt Signaling Pathway
Anaphase Promoting Complex
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein....
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

